World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
100
Citations
41536
World Ranking
722
National Ranking
65

Medicine

D-Index
100
Citations
41718
World Ranking
8216
National Ranking
807

Overview

Mary Ramsay is affiliated with Public Health England in the United Kingdom. Their research contributions primarily focus on infectious diseases, epidemiology, and public health, with a significant number of publications in the field of medicine. Their work frequently addresses SARS-CoV-2 and COVID-19 research, including vaccine coverage and hesitancy, clinical research studies, and epidemiological studies related to respiratory infections.

The major fields of study for Ramsay include:

  • Medicine

Their subfields of study further specify areas such as:

  • Infectious Diseases
  • Epidemiology
  • Health
  • Microbiology
  • Modeling and Simulation

Key research topics covered by Ramsay include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 detection and testing
  • Respiratory viral infections research
  • Pneumonia and Respiratory Infections
  • COVID-19 epidemiological studies

Several recent papers highlight Ramsay's involvement in important studies related to COVID-19 vaccines and infection dynamics:

  • Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant, 2021, published in New England Journal of Medicine
  • Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study, 2021, published in BMJ
  • COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study, 2021, published in The Lancet
  • SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN), 2021, published in The Lancet
  • Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study, 2020, published in The Lancet Infectious Diseases

Ramsay frequently collaborates with a group of coauthors, including:

  • Shamez Ladhani
  • Nick Andrews
  • Kevin Brown
  • Jamie Lopez Bernal
  • Gayatri Amirthalingam

Their work appears in several publication venues with multiple contributions, notably:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Journal of Infection
  • The Lancet Infectious Diseases
  • Eurosurveillance

Best Publications

  • Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

    Jamielopez L. Bernal;Nick Andrews;Charlotte Gower;Eileen Gallagher

  • Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.

    James Lopez Bernal;James Lopez Bernal;James Lopez Bernal;Nicholas Andrews;Nicholas Andrews;Charlotte Gower;Chris Robertson

  • Global epidemiology of meningococcal disease.

    Lee H. Harrison;Caroline L. Trotter;Mary E. Ramsay

  • Effectiveness of maternal pertussis vaccination in England: an observational study

    Gayatri Amirthalingam;Nick Andrews;Helen Campbell;Sonia Ribeiro

  • COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.

    Victoria Jane Hall;Victoria Jane Hall;Sarah Foulkes;Ayoub Saei;Nick Andrews;Nick Andrews

  • Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.

    Caroline L Trotter;Nick J Andrews;Edward B Kaczmarski;Elizabeth Miller

  • SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).

    V J Hall;S Foulkes;A Charlett;A Atti

  • Immunisation against infectious disease

    David Salisbury;Mary Ramsay;Karen Noakes

  • Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.

    Simon de Lusignan;Simon de Lusignan;Jienchi Dorward;Jienchi Dorward;Ana Correa;Ana Correa;Nicholas Jones

  • Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

    E. Miller;D. Salisbury;M. Ramsay

  • Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

    Shamez N Ladhani;Shamez N Ladhani;Sarah Collins;Abdelmajid Djennad;Carmen L Sheppard

  • Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

    Mary E Ramsay;Nick J Andrews;Caroline L Trotter;Edward B Kaczmarski

  • Factors underlying parental decisions about combination childhood vaccinations including MMR: A systematic review

    Katrina F. Brown;J. Simon Kroll;Michael J. Hudson;Mary Ramsay

  • Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

    Xinxue Liu;Robert H Shaw;Arabella S V Stuart;Melanie Greenland

  • Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.

    Katherine A Twohig;Tommy Nyberg;Asad Zaidi;Simon Thelwall

  • Global epidemiology of invasive meningococcal disease.

    Rabab Z Jafri;Asad Ali;Nancy E Messonnier;Carol Tevi-Benissan

  • Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

    Mary E Ramsay;Nick Andrews;Edward B Kaczmarski;Elizabeth Miller

  • Measles outbreaks in a population with declining vaccine uptake.

    V. A. A. Jansen;N. Stollenwerk;H. J. Jensen;M. E. Ramsay

  • A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012–2013

    Gavin Dabrera;Gayatri Amirthalingam;Nick Andrews;Helen Campbell

  • Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

    Alasdair P S Munro;Alasdair P S Munro;Leila Janani;Victoria Cornelius;Parvinder K Aley

Frequent Co-Authors

Shamez N. Ladhani
Shamez N. Ladhani UK Health Security Agency
Nick Andrews
Nick Andrews Salk Institute for Biological Studies
Gayatri Amirthalingam
Gayatri Amirthalingam Public Health England
Mary P. E. Slack
Mary P. E. Slack Griffith University
Ray Borrow
Ray Borrow Manchester Royal Infirmary
Kevin E. Brown
Kevin E. Brown Public Health England
Maria Zambon
Maria Zambon Public Health England
Paul T. Heath
Paul T. Heath St George's, University of London
Caroline L. Trotter
Caroline L. Trotter University of Cambridge
Matthew Hickman
Matthew Hickman University of Bristol

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your education through related online degrees can open diverse career opportunities in healthcare and research. Many professionals choose to enhance their qualifications by enrolling in accelerated and flexible nursing programs, which often complement immunology expertise.

For example, the accelerated np program offers a fast track to becoming a Nurse Practitioner, a role that frequently works closely with immunologists on patient care and treatment plans. Similarly, non-nurses can enter the field of healthcare through the best online bsn programs for non nurses, which provide accessible options for career changers aiming to build a foundation in nursing.

If time is a critical factor, consider exploring 12-month accelerated nursing programs, designed for those who want to quickly gain essential nursing skills alongside their scientific knowledge. Additionally, starting with accredited lpn programs easy to get into can be an effective entry point into clinical roles that support immunology research and patient treatment.

Choosing the right online program can significantly broaden your career pathways, allowing you to leverage immunology expertise within nursing, healthcare management, or specialized clinical practices.

Best Scientists Citing Mary Ramsay

Trending Scientists

Recently Published Articles